Sensus Healthcare (SRTS) Income towards Parent Company (2016 - 2025)
Sensus Healthcare's (SRTS) quarterly Income towards Parent Company came in at -$3.2 million in Q4 2025, down 304.85% year-on-year from $1.5 million in Q4 2024, and down 235.84% quarter-over-quarter from -$943000.0 in Q3 2025.
Sensus Healthcare (SRTS) Income towards Parent Company (2016 - 2025) Analysis & Trends
Sensus Healthcare's Income towards Parent Company history runs 10 years deep, the most recent figure standing at -$3.2 million for Q4 2025.
- On a quarterly basis, Income towards Parent Company fell 304.85% year-over-year to -$3.2 million in Q4 2025; TTM through Mar 2026 was -$5.1 million, a 385.79% decrease from a year earlier, with the FY2025 full-year figure at -$7.7 million, down 216.13% from the prior year.
- Income towards Parent Company slipped to -$3.2 million in Q4 2025 per SRTS's latest filing, from -$943000.0 in the prior quarter.
- Across five years, Income towards Parent Company topped out at $5.3 million in Q4 2021 and bottomed at -$631.3 million in Q1 2022.
- The 5-year median for Income towards Parent Company is -$42000.0 (2021), against an average of -$31.0 million.
- Across the five-year window, Income towards Parent Company surged 1985.49% in 2021 and slumped 56517.94% in 2022, its largest moves.
- Year by year, Income towards Parent Company stood at $5.3 million in 2021, then sank by 46.8% to $2.8 million in 2022, then jumped by 48.82% to $4.2 million in 2023, then sank by 63.28% to $1.5 million in 2024, then plunged by 304.85% to -$3.2 million in 2025.
- Per Business Quant, the three latest SRTS Income towards Parent Company figures stand at -$3.2 million (Q4 2025), -$943000.0 (Q3 2025), and -$1.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Sensus Healthcare | 49.55 Mn | 31.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.17 Mn |
| Sep 30, 2025 | -943,000.00 |
| Jun 30, 2025 | -1.04 Mn |
| Mar 31, 2025 | -2.57 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 2.27 Mn |
| Dec 31, 2023 | 4.21 Mn |
| Sep 30, 2023 | -1.45 Mn |
| Jun 30, 2023 | -380,000.00 |
| Mar 31, 2023 | -1.89 Mn |
| Dec 31, 2022 | 2.83 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 3.52 Mn |
| Mar 31, 2022 | -631.29 Mn |
| Dec 31, 2021 | 5.32 Mn |
| Sep 30, 2021 | 195,000.00 |
| Jun 30, 2021 | -279,000.00 |
| Mar 31, 2021 | -1.12 Mn |